InvestorsHub Logo
Post# of 251820
Next 10
Followers 114
Posts 2958
Boards Moderated 0
Alias Born 06/28/2014

Re: maverick_1 post# 242382

Saturday, 11/19/2022 7:53:50 AM

Saturday, November 19, 2022 7:53:50 AM

Post# of 251820
Immuno Oncology GAME CHANGER from the DARK Cellar (2017 at 15 cts) into
The LIGHT(now $1.14) ..........

for it's Moonshot?

PEER Reviewed & co-authored by more than 70 physicians from leading institutions across the U.S., Canada, U.K. and Germany:

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

followed by JAMA Audio Interview with DXVAX L's
Principal Investigator UCLA's Head of Oncology
Dr.Linda Liau PhD, MBA:

https://edhub.ama-assn.org/jn-learning/audio-player/18738384?resultClick=1

"Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. Wikipedia
Books: Brain Tumor Immunotherapy
h-index: 77
Citations: 30,960
Affiliation: University of California, Los Angeles
Research interests: Brain Tumors, Brain Cancer, Neurosurgical Oncology"

DIFFERENT STROKES for DIFFERENT FOLKS

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.